Garvan Institute of Medical Research, 384 Victoria St, Darlinghurst, NSW 2010, Australia.
Department of Biochemistry, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Mol Metab. 2024 Jan;79:101845. doi: 10.1016/j.molmet.2023.101845. Epub 2023 Nov 25.
Although individual steps have been characterized, there is little understanding of the overall process whereby glucose co-ordinates the biosynthesis of insulin with its export out of the endoplasmic reticulum (ER) and incorporation into insulin secretory granules (ISGs). Here we investigate a role for the transcription factor CREB3L2 in this context.
MIN6 cells and mouse islets were analysed by immunoblotting after treatment with glucose, fatty acids, thapsigargin and various inhibitors. Knockdown of CREB3L2 was achieved using si or sh constructs by transfection, or viral delivery. In vivo metabolic phenotyping was conducted after deletion of CREB3L2 in β-cells of adult mice using Ins1-CreER. Islets were isolated for RNAseq and assays of glucose-stimulated insulin secretion (GSIS). Trafficking was monitored in islet monolayers using a GFP-tagged proinsulin construct that allows for synchronised release from the ER.
With a K ≈3.5 mM, glucose rapidly (T 0.9 h) increased full length (FL) CREB3L2 followed by a slower rise (T 2.5 h) in its transcriptionally-active cleavage product, P60 CREB3L2. Glucose stimulation repressed the ER stress marker, CHOP, and this was partially reverted by knockdown of CREB3L2. Activation of CREB3L2 by glucose was not due to ER stress, however, but a combination of O-GlcNAcylation, which impaired proteasomal degradation of FL-CREB3L2, and mTORC1 stimulation, which enhanced its conversion to P60. cAMP generation also activated CREB3L2, but independently of glucose. Deletion of CREB3L2 inhibited GSIS ex vivo and, following a high-fat diet (HFD), impaired glucose tolerance and insulin secretion in vivo. RNAseq revealed that CREB3L2 regulated genes controlling trafficking to-and-from the Golgi, as well as a broader cohort associated with β-cell compensation during a HFD. Although post-Golgi trafficking appeared intact, knockdown of CREB3L2 impaired the generation of both nascent ISGs and proinsulin condensates in the Golgi, implying a defect in ER export of proinsulin and/or its processing in the Golgi.
The stimulation of CREB3L2 by glucose defines a novel, rapid and direct mechanism for co-ordinating the synthesis, packaging and storage of insulin, thereby minimizing ER overload and optimizing β-cell function under conditions of high secretory demand. Upregulation of CREB3L2 also potentially contributes to the benefits of GLP1 agonism and might in itself constitute a novel means of treating β-cell failure.
尽管已经对各个步骤进行了描述,但对于葡萄糖协调胰岛素在内质网(ER)中输出和纳入胰岛素分泌颗粒(ISG)的生物合成的整个过程知之甚少。在这里,我们研究了转录因子 CREB3L2 在这种情况下的作用。
用葡萄糖、脂肪酸、thapsigargin 和各种抑制剂处理 MIN6 细胞和小鼠胰岛后,通过免疫印迹进行分析。通过转染或病毒传递使用 si 或 sh 构建体实现 CREB3L2 的敲低。在使用 Ins1-CreER 删除成年小鼠β细胞中的 CREB3L2 后,进行体内代谢表型分析。使用 GFP 标记的前胰岛素构建体在胰岛单层中监测运输,该构建体允许从 ER 同步释放。
葡萄糖以 K ≈3.5mM 的浓度快速(T 0.9h)增加全长(FL)CREB3L2,然后以较慢的速度(T 2.5h)增加其转录活性切割产物 P60 CREB3L2。葡萄糖刺激抑制内质网应激标志物 CHOP,而 CREB3L2 的敲低部分逆转了这一作用。葡萄糖激活 CREB3L2 不是由于内质网应激,而是由于 O-GlcNAcylation,其削弱了 FL-CREB3L2 的蛋白酶体降解,以及 mTORC1 刺激,其增强了其转化为 P60。cAMP 的产生也激活了 CREB3L2,但与葡萄糖无关。CREB3L2 的缺失抑制了体外 GSIS,并且在高脂肪饮食(HFD)后,体内葡萄糖耐量和胰岛素分泌受损。RNAseq 显示 CREB3L2 调节控制从高尔基体运输到高尔基体和从高尔基体运输的基因,以及与 HFD 期间β细胞补偿相关的更广泛的群组。尽管高尔基后运输似乎完整,但 CREB3L2 的敲低损害了新生 ISG 和高尔基中前胰岛素凝聚体的产生,这意味着胰岛素原的内质网输出和/或其在高尔基体中的加工存在缺陷。
葡萄糖对 CREB3L2 的刺激定义了一种新的、快速和直接的机制,用于协调胰岛素的合成、包装和储存,从而最大限度地减少 ER 过载并优化高分泌需求下的β细胞功能。CREB3L2 的上调也可能有助于 GLP1 激动剂的益处,并且本身可能构成治疗β细胞衰竭的新方法。